Copyright Reports & Markets. All rights reserved.

Global DPT Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global DPT Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 DTaP
    • 1.3.3 Tdap
    • 1.3.4 DTwP
  • 1.4 Market Analysis by Age
    • 1.4.1 Overview: Global DPT Vaccines Consumption Value by Age: 2021 Versus 2025 Versus 2032
    • 1.4.2 12 Months Below
    • 1.4.3 12 Months Above
  • 1.5 Global DPT Vaccines Market Size & Forecast
    • 1.5.1 Global DPT Vaccines Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global DPT Vaccines Sales Quantity (2021-2032)
    • 1.5.3 Global DPT Vaccines Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi Pasteur
    • 2.1.1 Sanofi Pasteur Details
    • 2.1.2 Sanofi Pasteur Major Business
    • 2.1.3 Sanofi Pasteur DPT Vaccines Product and Services
    • 2.1.4 Sanofi Pasteur DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Pasteur Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK DPT Vaccines Product and Services
    • 2.2.4 GSK DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Mitsubishi Tanabe Pharma
    • 2.3.1 Mitsubishi Tanabe Pharma Details
    • 2.3.2 Mitsubishi Tanabe Pharma Major Business
    • 2.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
    • 2.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.4 KM Biologics
    • 2.4.1 KM Biologics Details
    • 2.4.2 KM Biologics Major Business
    • 2.4.3 KM Biologics DPT Vaccines Product and Services
    • 2.4.4 KM Biologics DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 KM Biologics Recent Developments/Updates
  • 2.5 Wuhan Institute of Biological Products
    • 2.5.1 Wuhan Institute of Biological Products Details
    • 2.5.2 Wuhan Institute of Biological Products Major Business
    • 2.5.3 Wuhan Institute of Biological Products DPT Vaccines Product and Services
    • 2.5.4 Wuhan Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
  • 2.6 Walvax Biotechnology
    • 2.6.1 Walvax Biotechnology Details
    • 2.6.2 Walvax Biotechnology Major Business
    • 2.6.3 Walvax Biotechnology DPT Vaccines Product and Services
    • 2.6.4 Walvax Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Walvax Biotechnology Recent Developments/Updates
  • 2.7 Chengdu Institute of Biological Products
    • 2.7.1 Chengdu Institute of Biological Products Details
    • 2.7.2 Chengdu Institute of Biological Products Major Business
    • 2.7.3 Chengdu Institute of Biological Products DPT Vaccines Product and Services
    • 2.7.4 Chengdu Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
  • 2.8 Minhai Biotechnology
    • 2.8.1 Minhai Biotechnology Details
    • 2.8.2 Minhai Biotechnology Major Business
    • 2.8.3 Minhai Biotechnology DPT Vaccines Product and Services
    • 2.8.4 Minhai Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Minhai Biotechnology Recent Developments/Updates

3 Competitive Environment: DPT Vaccines by Manufacturer

  • 3.1 Global DPT Vaccines Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global DPT Vaccines Revenue by Manufacturer (2021-2026)
  • 3.3 Global DPT Vaccines Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of DPT Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 DPT Vaccines Manufacturer Market Share in 2025
    • 3.4.3 Top 6 DPT Vaccines Manufacturer Market Share in 2025
  • 3.5 DPT Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 DPT Vaccines Market: Region Footprint
    • 3.5.2 DPT Vaccines Market: Company Product Type Footprint
    • 3.5.3 DPT Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global DPT Vaccines Market Size by Region
    • 4.1.1 Global DPT Vaccines Sales Quantity by Region (2021-2032)
    • 4.1.2 Global DPT Vaccines Consumption Value by Region (2021-2032)
    • 4.1.3 Global DPT Vaccines Average Price by Region (2021-2032)
  • 4.2 North America DPT Vaccines Consumption Value (2021-2032)
  • 4.3 Europe DPT Vaccines Consumption Value (2021-2032)
  • 4.4 Asia-Pacific DPT Vaccines Consumption Value (2021-2032)
  • 4.5 South America DPT Vaccines Consumption Value (2021-2032)
  • 4.6 Middle East & Africa DPT Vaccines Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global DPT Vaccines Sales Quantity by Type (2021-2032)
  • 5.2 Global DPT Vaccines Consumption Value by Type (2021-2032)
  • 5.3 Global DPT Vaccines Average Price by Type (2021-2032)

6 Market Segment by Age

  • 6.1 Global DPT Vaccines Sales Quantity by Age (2021-2032)
  • 6.2 Global DPT Vaccines Consumption Value by Age (2021-2032)
  • 6.3 Global DPT Vaccines Average Price by Age (2021-2032)

7 North America

  • 7.1 North America DPT Vaccines Sales Quantity by Type (2021-2032)
  • 7.2 North America DPT Vaccines Sales Quantity by Age (2021-2032)
  • 7.3 North America DPT Vaccines Market Size by Country
    • 7.3.1 North America DPT Vaccines Sales Quantity by Country (2021-2032)
    • 7.3.2 North America DPT Vaccines Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe DPT Vaccines Sales Quantity by Type (2021-2032)
  • 8.2 Europe DPT Vaccines Sales Quantity by Age (2021-2032)
  • 8.3 Europe DPT Vaccines Market Size by Country
    • 8.3.1 Europe DPT Vaccines Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe DPT Vaccines Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific DPT Vaccines Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific DPT Vaccines Sales Quantity by Age (2021-2032)
  • 9.3 Asia-Pacific DPT Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific DPT Vaccines Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific DPT Vaccines Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America DPT Vaccines Sales Quantity by Type (2021-2032)
  • 10.2 South America DPT Vaccines Sales Quantity by Age (2021-2032)
  • 10.3 South America DPT Vaccines Market Size by Country
    • 10.3.1 South America DPT Vaccines Sales Quantity by Country (2021-2032)
    • 10.3.2 South America DPT Vaccines Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa DPT Vaccines Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa DPT Vaccines Sales Quantity by Age (2021-2032)
  • 11.3 Middle East & Africa DPT Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa DPT Vaccines Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa DPT Vaccines Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 DPT Vaccines Market Drivers
  • 12.2 DPT Vaccines Market Restraints
  • 12.3 DPT Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of DPT Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of DPT Vaccines
  • 13.3 DPT Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 DPT Vaccines Typical Distributors
  • 14.3 DPT Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global DPT Vaccines market size was valued at US$ 6136 million in 2025 and is forecast to a readjusted size of US$ 7744 million by 2032 with a CAGR of 3.4% during review period.
    In 2024, global DPT Vaccines production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus. In this report, we cover all the DTP-containing vaccines. Gross margin for the DPT Vaccines in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.
    The global DPT Vaccines market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The DPT Vaccines industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for DPT Vacciness is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
    This report is a detailed and comprehensive analysis for global DPT Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global DPT Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2021-2032
    Global DPT Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2021-2032
    Global DPT Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2021-2032
    Global DPT Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for DPT Vaccines
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global DPT Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    DPT Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    DTaP
    Tdap
    DTwP
    Market segment by Composition
    Acellular Vaccines
    Whole-cell Vaccines
    Market segment by User
    Below 12 Months
    Above 12 Months
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Sanofi Pasteur
    GSK
    Mitsubishi Tanabe Pharma
    KM Biologics
    Wuhan Institute of Biological Products
    Walvax Biotechnology
    Chengdu Institute of Biological Products
    Minhai Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe DPT Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales quantity, revenue, and global market share of DPT Vaccines from 2021 to 2026.
    Chapter 3, the DPT Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and DPT Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccines.
    Chapter 14 and 15, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now